Login to Your Account



Zai has arrived; inks deal with Sanofi for preclinical COPD drugs

By Shannon Ellis
Staff Writer

Wednesday, August 20, 2014

SHANGHAI – Newly minted Zai Lab Ltd., of Shanghai, has made its eagerly awaited debut announcement, obtaining global rights to two Sanofi SA preclinical compounds for chronic respiratory diseases.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription